인쇄하기
취소

Clinical data to cross recognize between Korea and Japan.

Published: 2005-06-24 07:00:00
Updated: 2005-06-24 07:00:00
The pharmaceutical manufacturers associations of Korea and Japan have acknowledged that the mutual recognition of clinical study data would make an important process for commercializing a new drug.

The Korean and Japanese pharmaceutical manufacturers association held a joint seminar in Japan on June 16 under the title of "Clinical development and pharmaceutical affairs controls" for the rec...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.